Skip to content

Drug interactions

Ipratropium-salbutamol + Xylometazoline

Severity: Minor

Ipratropium-salbutamol and Xylometazoline: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Xylometazoline is a topical nasal decongestant with limited systemic absorption at recommended doses. Combined with salbutamol, additive sympathomimetic effects such as raised heart rate and blood pressure are possible but uncommon.

What this interaction means in plain words

Ipratropium-salbutamol and Xylometazoline have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Ipratropium-salbutamol belongs to Respiratory; Xylometazoline belongs to Respiratory.

Evidence level: Low

Why it happens

Additive adrenergic stimulation from a systemically absorbed alpha-agonist and a beta2-agonist.

What to do

No routine action is needed with recommended use; advise patients with hypertension or arrhythmia to avoid exceeding the labelled nasal dose or duration.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ipratropium-salbutamol and Xylometazoline, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Ipratropium-salbutamol with Xylometazoline?

MediHelp rates the interaction as minor. Ipratropium-salbutamol and Xylometazoline have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Xylometazoline is a topical nasal decongestant with limited systemic absorption at recommended doses. Combined with salbutamol, additive sympathomimetic effects such as raised heart rate and blood pressure are possible but uncommon.

How serious is the interaction between Ipratropium-salbutamol and Xylometazoline?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine action is needed with recommended use; advise patients with hypertension or arrhythmia to avoid exceeding the labelled nasal dose or duration.

What other medicines interact with Ipratropium-salbutamol?

MediHelp also lists interactions of Ipratropium-salbutamol with, for example, Amisulpride, Arsenic trioxide, Carvedilol. The full list is on the Ipratropium-salbutamol page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in